Dr. Mashayekhi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1215 21st Ave S
Fl 8
Nashville, TN 37232Phone+1 615-343-8332Fax+1 615-343-8346
Summary
- Dr. Mona Mashayekhi is an endocrinologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. She received her medical degree from Washington University School of Medicine in St. Louis and has been in practice 7 years. She specializes in diabetes and endocrinology.
Education & Training
Vanderbilt University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2017 - 2020- Vanderbilt University Medical CenterChief Residency, Internal Medicine, 2016 - 2017
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2014 - 2016
Washington University in St. Louis School of MedicineClass of 2013
University of ChicagoBA, Biology, 2000 - 2004
Certifications & Licensure
TN State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- CD3+ T-cell: CD14+ monocyte complexes are dynamic and increased with HIV and glucose intolerance.Laventa M Obare, Joshua Simmons, Jared Oakes, Xiuqi Zhang, Cindy Nochowicz
Journal of Immunology. 2025-02-28 - 1 citationsThe Primacy of Adipose Tissue Gene Expression and Plasma Lipidome in Cardiometabolic Disease in Persons With HIV.Samuel S Bailin, Siyuan Ma, Andrew S Perry, James G Terry, John Jeffrey Carr
The Journal of Infectious Diseases. 2025-02-20 - 1 citationsSingle-Cell Analysis of Subcutaneous Fat Reveals Profibrotic Cells That Correlate With Visceral Adiposity in HIV.Samuel S Bailin, Curtis L Gabriel, Rama D Gangula, LaToya Hannah, Sangeeta Nair
The Journal of Clinical Endocrinology and Metabolism. 2024-12-18
Press Mentions
Pairing Drugs like Ozempic with SGLT2 Meds May Help Reduce Heart Attack, Stroke RisksJuly 10th, 2024- Researchers Find Signs That Gestational Diabetes May Increase Risk of Type 1 DiabetesMay 25th, 2021
- VUMC in the News: Sept. 19, 2023September 15th, 2023
- Join now to see all
Grant Support
- The Effect of SGLT2 Inhibition on Adipose Tissue Inflammation and Endothelial FunctionVANDERBILT UNIVERSITY MEDICAL CENTER2023–2028
Professional Memberships
- Endocrine SocietyMember
- The Obesity SocietyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
